INT120056

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.14
First Reported 2004
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 6
Disease Relevance 2.89
Pain Relevance 0.53

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (NFIC) intracellular (NFIC) DNA binding (NFIC)
Anatomy Link Frequency
thyroid 1
nerve 1
NFIC (Homo sapiens)
Pain Link Frequency Relevance Heat
neuralgia 4 98.72 Very High Very High Very High
Neurobehavioral 10 95.48 Very High Very High Very High
depression 3 91.12 High High
Quantitative sensory testing 20 76.84 Quite High
Action potential 72 73.60 Quite High
diabetic neuropathy 8 47.00 Quite Low
cva 2 10.00 Low Low
headache 1 10.00 Low Low
unmyelinated 12 5.00 Very Low Very Low Very Low
Neuritis 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Neuropathic Pain 96 99.30 Very High Very High Very High
Neuralgia 4 98.72 Very High Very High Very High
Nervous System Injury 44 97.24 Very High Very High Very High
Mycobacterium Infection 128 96.40 Very High Very High Very High
Dissociative Disorders 1 92.16 High High
Depression 3 91.12 High High
Diabetic Nephropathy 8 84.00 Quite High
Diplopia 2 78.72 Quite High
Brain Injury 58 68.96 Quite High
Diabetes Mellitus 4 66.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Hormone level evaluation revealed a low free thyroxine index and elevated prolactin levels, and normal levels of thyroid stimulating hormone, growth hormone, insulin-like growth factor type 1, and cortisol.
Gene_expression (levels) of factor type 1 in thyroid
1) Confidence 0.14 Published 2004 Journal Endocr Pract Section Body Doc Link 15256330 Disease Relevance 0.08 Pain Relevance 0
Although sensory and motor neuropathy was much more widespread than the NFI detected by MFT and VMT, these tests were still validated by the current results.
Gene_expression (detected) of NFI associated with neuropathic pain
2) Confidence 0.07 Published 2008 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2270341 Disease Relevance 0.74 Pain Relevance 0
Early detection and treatment of NFI is therefore seen as a top priority [11].
Gene_expression (detection) of NFI
3) Confidence 0.06 Published 2008 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2270341 Disease Relevance 0.87 Pain Relevance 0
Table 3 shows the relationship between duration of onset of clinically detectable NFI (MFT and VMT) and the duration of impairment as measured with neurophysiological tests.
Gene_expression (detectable) of NFI
4) Confidence 0.05 Published 2008 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2270341 Disease Relevance 0 Pain Relevance 0.22
Even in patients with no clinical signs of reaction, no nerve tenderness, no clinically evident NFI (detectable by MFT or VMT), or symptoms of nerve pain, definite evidence of silent sensory and/or motor neuropathy was found (ulnar up to 26%, RC 50%, and sural 47%).
Gene_expression (detectable) of NFI in nerve associated with neuralgia and neuropathic pain
5) Confidence 0.05 Published 2008 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2270341 Disease Relevance 0.54 Pain Relevance 0.14
However, in subsequent studies the authors have compared the NFI (Johnston et al 2006) with functional measure such as FIM (Hall et al 1993).
Gene_expression (compared) of NFI
6) Confidence 0.05 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2654797 Disease Relevance 0.66 Pain Relevance 0.18

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox